| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.1M | +87.4% |
| Cost of Revenue | $12.5M | +91.6% |
| Gross Profit | $10.5M | +82.6% |
| R&D Expense | $2.8M | +2.8% |
| SG&A Expense | $11.2M | +16.0% |
| Operating Income | -$3.5M | +47.2% |
| Pre-tax Income | -$57.5M | -451.0% |
| Income Tax | $0 | — |
| Net Income | -$57.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.4M | +265.3% |
| Current Assets | $12.7M | +122.3% |
| Total Assets | $13.7M | +96.3% |
| Current Liabilities | $5.7M | -52.4% |
| Total Liabilities | $66.7M | +183.1% |
| Stockholders' Equity | -$53.0M | -219.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.5M | -97.6% |
| Financing Cash Flow | $14.8M | +141.6% |
| -451.0% |
| EPS (Basic) | -$2.34 | -295.0% |
| EPS (Diluted) | -$2.34 | -392.5% |